This report contains market size and forecasts of T-Cell Immunotherapy in Global, including the following market information:
Global T-Cell Immunotherapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global T-Cell Immunotherapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell Immunotherapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global T-Cell Immunotherapy Market Segment Percentages, By Type, 2020 (%)
CAR-T
TCR
TIL Therapies
China T-Cell Immunotherapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China T-Cell Immunotherapy Market Segment Percentages, By Application, 2020 (%)
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Global T-Cell Immunotherapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total T-Cell Immunotherapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total T-Cell Immunotherapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Immunotherapy Overall Market Size
2.1 Global T-Cell Immunotherapy Market Size: 2021 VS 2027
2.2 Global T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Immunotherapy Players in Global Market
3.2 Top Global T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Immunotherapy Market Size Markets, 2021 & 2027
4.1.2 CAR-T
4.1.3 TCR
4.1.4 TIL Therapies
4.2 By Type - Global T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Immunotherapy Revenue, 2016-2021
4.2.2 By Type - Global T-Cell Immunotherapy Revenue, 2022-2027
4.2.3 By Type - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Immunotherapy Market Size, 2021 & 2027
5.1.2 Stomach Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophagus Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - Global T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Immunotherapy Revenue, 2016-2021
5.2.2 By Application - Global T-Cell Immunotherapy Revenue, 2022-2027
5.2.3 By Application - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global T-Cell Immunotherapy Market Size, 2021 & 2027
6.2 By Region - Global T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Immunotherapy Revenue, 2016-2021
6.2.2 By Region - Global T-Cell Immunotherapy Revenue, 2022-2027
6.2.3 By Region - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America T-Cell Immunotherapy Revenue, 2016-2027
6.3.2 US T-Cell Immunotherapy Market Size, 2016-2027
6.3.3 Canada T-Cell Immunotherapy Market Size, 2016-2027
6.3.4 Mexico T-Cell Immunotherapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe T-Cell Immunotherapy Revenue, 2016-2027
6.4.2 Germany T-Cell Immunotherapy Market Size, 2016-2027
6.4.3 France T-Cell Immunotherapy Market Size, 2016-2027
6.4.4 U.K. T-Cell Immunotherapy Market Size, 2016-2027
6.4.5 Italy T-Cell Immunotherapy Market Size, 2016-2027
6.4.6 Russia T-Cell Immunotherapy Market Size, 2016-2027
6.4.7 Nordic Countries T-Cell Immunotherapy Market Size, 2016-2027
6.4.8 Benelux T-Cell Immunotherapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia T-Cell Immunotherapy Revenue, 2016-2027
6.5.2 China T-Cell Immunotherapy Market Size, 2016-2027
6.5.3 Japan T-Cell Immunotherapy Market Size, 2016-2027
6.5.4 South Korea T-Cell Immunotherapy Market Size, 2016-2027
6.5.5 Southeast Asia T-Cell Immunotherapy Market Size, 2016-2027
6.5.6 India T-Cell Immunotherapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America T-Cell Immunotherapy Revenue, 2016-2027
6.6.2 Brazil T-Cell Immunotherapy Market Size, 2016-2027
6.6.3 Argentina T-Cell Immunotherapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Immunotherapy Revenue, 2016-2027
6.7.2 Turkey T-Cell Immunotherapy Market Size, 2016-2027
6.7.3 Israel T-Cell Immunotherapy Market Size, 2016-2027
6.7.4 Saudi Arabia T-Cell Immunotherapy Market Size, 2016-2027
6.7.5 UAE T-Cell Immunotherapy Market Size, 2016-2027
7 Players Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Corporate Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune T-Cell Immunotherapy Major Product Offerings
7.1.4 Adaptimmune T-Cell Immunotherapy Revenue in Global (2016-2021)
7.1.5 Adaptimmune Key News
7.2 Altor Bioscience Corporation
7.2.1 Altor Bioscience Corporation Corporate Summary
7.2.2 Altor Bioscience Corporation Business Overview
7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Major Product Offerings
7.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in Global (2016-2021)
7.2.5 Altor Bioscience Corporation Key News
7.3 Cellectis
7.3.1 Cellectis Corporate Summary
7.3.2 Cellectis Business Overview
7.3.3 Cellectis T-Cell Immunotherapy Major Product Offerings
7.3.4 Cellectis T-Cell Immunotherapy Revenue in Global (2016-2021)
7.3.5 Cellectis Key News
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Corporate Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics T-Cell Immunotherapy Major Product Offerings
7.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in Global (2016-2021)
7.4.5 Juno Therapeutics Key News
7.5 Kite Pharma
7.5.1 Kite Pharma Corporate Summary
7.5.2 Kite Pharma Business Overview
7.5.3 Kite Pharma T-Cell Immunotherapy Major Product Offerings
7.5.4 Kite Pharma T-Cell Immunotherapy Revenue in Global (2016-2021)
7.5.5 Kite Pharma Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis T-Cell Immunotherapy Major Product Offerings
7.6.4 Novartis T-Cell Immunotherapy Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Takara Bio
7.7.1 Takara Bio Corporate Summary
7.7.2 Takara Bio Business Overview
7.7.3 Takara Bio T-Cell Immunotherapy Major Product Offerings
7.4.4 Takara Bio T-Cell Immunotherapy Revenue in Global (2016-2021)
7.7.5 Takara Bio Key News
7.8 Unum Therapeutics
7.8.1 Unum Therapeutics Corporate Summary
7.8.2 Unum Therapeutics Business Overview
7.8.3 Unum Therapeutics T-Cell Immunotherapy Major Product Offerings
7.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in Global (2016-2021)
7.8.5 Unum Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Immunotherapy Market Drivers in Global Market
Table 3. T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Immunotherapy in Global Market
Table 5. Top T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global T-Cell Immunotherapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics